ARCHIVES

DCCR Free Up $5 Million; New Policy Limits Core Support

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12

September 2, 1988

AACR Elion Award Deadline Is Jan. 10

September 16, 1994

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013